BFEC
LABU icon

Benjamin F. Edwards & Company’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Benjamin F. Edwards & Company’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed – – 2134
2023
Q3 		$0 Buy
+1
New +$103 ﹤0.01% 1782

Other funds holding LABU

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Benjamin F. Edwards & Company's LABU Position: Q4 2023 in Review

Benjamin F. Edwards & Company sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2023, closing a stake of 1 share.

Benjamin F. Edwards & Company first reported a position in LABU in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 41 funds tracked by Wall St. Rank hold LABU as of Q4 2023.

  • Benjamin F. Edwards & Company reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2023 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 1 Direxion Daily S&P Biotech Bull 3X ETF share in Q4 2023.
  • Benjamin F. Edwards & Company first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2023 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $0 in Q3 2023.
  • 41 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2023, filed 6 Feb 2024.